Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

context of the agreement

signed with Merck in March 2006

-- Euro 1.0 million received from Pfizer in April 2007, following the

review of an Investigational New Drug (IND) submission by the U.S. FDA

for a new experimental medicine for the treatment of glaucoma,

developed under the collaboration agreement signed between Pfizer and

NicOx in August 2004

-- Euro 5.0 million received from Merck in July 2007, following the

initiation of the first in a series of planned clinical studies for the

first selected drug candidate, in accordance with the companies' major

collaborative agreement to develop new nitric oxide-donating

antihypertensive agents using NicOx' proprietary technology

These amounts, received by the Company, result from a firm commitment by the other contracting party and have been immediately recognized in revenues because NicOx will not have continuing involvement in the future development of the compounds that are the subject of the collaboration agreements mentioned above.

During the financial year 2007, NicOx also recognized the following sums, initially recorded as prepaid income, in revenues:

-- Euro 2.5 million corresponding to the initial payment of euro 5.0

million from Pfizer as a technology exclusivity fee, following the

March 2006 agreement that granted Pfizer rights to an exclusive

worldwide license to develop and commercialize new drug candidates

using NicOx' proprietary technology in the field of ophthalmology

-- Euro 3.0 million corresponding to the funding of the research

collaboration, pursuant to the above referenced agreement signed with

Pfizer in March 2006.

-- Euro 3.8 million corresponding to the initial payment of euro 9.2

million received from Merck following the signature in March 2006 of a

collaboration agreement for new antih
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and LYON, France , Dec. ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ... developing an ultra-rapid insulin, known as BioChaperone Lispro, for ... diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology ... Lilly and Adocia will develop BioChaperone Lispro with the ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... 17, 2014  Beamz Interactive, Inc. (OTCQB: BZIC), ... today announced that it has signed an agreement ... supplier of innovative prosthetic, orthotic and assistive technology ... the agreement, RSL Steeper will promote and supply ... for use within UK residential care facilities through ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... N.J., March 3, 2011 ConvaTec Healthcare, a world-leading ... community and hospital care, today announced that, recognizing favorable ... option to refinance all or a portion of its ... 22, 2010. While the year-end audit ...
... A new report released by the UNT Health ... East Texas are breathing a little easier due in part ... center,s Center for Professional and Continuing Education regarding ... (COPD).  The report shows that the educational program contributed ...
Cached Medicine Technology:ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 2Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 4
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the table ... kind, the site has provided its faithful users with everything ... It uniquely combines the benefits of platforms like Craigslist, ... the masses. Assuring the potent herb’s followers it’s well ... approval. , Shane Chattin, Owner of Cannabis Classifieds ...
(Date:12/20/2014)... BambooIndustry.com is a leading ... has announced its bamboo flooring promotion for the ... from certified suppliers, and offers the best bamboo ... the current promotion, all customers can enjoy a ... say they know BambooIndustry.com from press releases. , ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its ... Christmas Sale, offering big discounts on all of its special ... idea to own a perfect wedding gown. If you have ... then come to LunaDress. Many different wedding dress styles and ... website now and enjoy the current special offer, up to ...
(Date:12/20/2014)... December 20, 2014 Recently, VogueQueen.com, a ... VogueQueen Big Sale Online for 2015. Great ... All new and old consumers can get a discount, ... at the company’s website before January 30, 2015. , ... dresses and launched a prom dress promotion. Many customers ...
(Date:12/20/2014)... Atore, Inc, (San Francisco, CA CEO: Masashi ... focused portal on December 17th, 2014. , One ... US and Japan. , MERRY BIRTHDAY SITE : ... , MERRY BIRTHDAY MESSAGE is part of 5 future ... Features, Choose from thousands of stock photos to decorate ...
Breaking Medicine News(10 mins):Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... Centers to Offer Free Health Assessments, HARRISBURG, Pa., ... invited Pennsylvanians to take advantage of,free health assessments being ... Sept. 21. The free health services are available in,conjunction ... which is observed on,Sept. 18., "Nearly 800,000 Pennsylvanians ...
... NEW YORK, Sept. 17 ExL Pharma is ... cover many of the leading,issues that are impacting ... networking opportunities for Clinical, R&D,Regulatory and Medical Affairs ... medical technology companies. Listed below are details ...
... For orthopaedic implants to be successful, bone must meld ... shoulders are made of. A team of Brown University ... material that could significantly increase this success rate. , ... material around and chemically treated it and applied ...
... American College of Physicians (ACP) will publish "The Fenway ... Dr. Ken Mayer, and Hilary Goldhammer of The Fenway ... of Beth Israel Deaconess Medical Center, the textbook is ... the unique health care needs of sexual and gender ...
... to Accelerate Growth Initiatives, ROCHESTER, N.Y., Sept. ... it has completed a private placement of,$4,350,000 of ... a,group of institutional and other accredited investors. VirtualScopics,currently ... offering to expand its,sales and marketing efforts, software ...
... provides patient HIV tropism status, needed to initiate ... ... CCR5 antagonist., MALIBU, Calif., Sept. 17 Pathway ... assay (HTA) for determining the co-receptor tropism,status of HIV ...
Cached Medicine News:Health News:Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs 2Health News:Bone-growing nanomaterial could improve orthopaedic implants 2Health News:American College of Physicians publishes 'The Fenway Guide to LGBT Health' 2Health News:VirtualScopics Announces $4.35 Million Private Placement 2Health News:VirtualScopics Announces $4.35 Million Private Placement 3Health News:Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay 2Health News:Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: